CUE
Cue Biopharma, Inc.
Company overview
- Market capitalization
- $199.41M
- Employees
- 29
- Latest publication
- 2026-09-29
About Cue Biopharma, Inc.
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops a novel class of injectable therapeutics to selectively engage and modulate targeted, disease relevant T cells in the United States. Its lead drug product candidate is the CUE-401, a bifunctional fusion protein designed to promote immune tolerance by inducing iTregs from Teff cells which is in preclinical trial; and CUE-501, a treatment of autoimmune disease via anti-viral T cell-mediated depletion of B cells. The company also develops CUE-101, which is in phase 1b clinical trial to treat HPV+ recurrent metastatic, or head and neck squamous cell carcinoma in second line, and beyond patients as a monotherapy, as well as in phase 1b clinical trial for the treatment of head and neck squamous cell carcinoma as a first line, therapy in combination with standard of care KEYTRUDA; and CUE-102, which is in phase 1b clinical trial as a monotherapy in late line recurrent metastatic WT1+ colorectal, gastric, ovarian, and pancreatic cancer. It has collaboration agreements with LG Chem, Ltd. for the development of CUE-101 and CUE-102 Immuno-STATs; collaboration and option agreement with Ono Pharmaceutical Co., Ltd to development and commercialization rights for CUE-401; and license agreement with Albert Einstein College of Medicine. The company was formerly known as Imagen Biopharma, Inc. and changed its name to Cue Biopharma, Inc. in October 2016. Cue Biopharma, Inc. was incorporated in 2014 and is headquartered in Boston, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 7,877,000USD | 5,686,000USD | 21,942,000USD | 2,149,000USD | 2,954,000USD | 421,000USD | 1,576,000USD | 3,336,000USD |
| Research Development | 49,007,000USD | 6,897,000USD | 16,532,000USD | 4,686,000USD | 7,910,000USD | 8,547,000USD | 7,184,000USD | 9,381,000USD |
| Selling General Administrative | 46,565,000USD | 4,152,000USD | 3,452,000USD | 4,939,000USD | 3,675,000USD | 4,173,000USD | 4,021,000USD | 2,867,000USD |
| General And Administrative Expenses | 46,565,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 95,572,000USD | 11,049,000USD | 19,984,000USD | 9,614,000USD | 11,589,000USD | 12,720,000USD | 11,209,000USD | 12,151,000USD |
| Operating Income | -87,695,000USD | -5,363,000USD | 1,958,000USD | -7,544,000USD | -8,635,000USD | -12,299,000USD | -9,633,000USD | -8,815,000USD |
| Total Other Income Expense Net | -65,372,000USD | 185,000USD | 127,000USD | 96,000USD | 153,000USD | 42,000USD | 137,000USD | 155,000USD |
| Net Interest Income | -5,000USD | 175,000USD | 107,000USD | 147,000USD | 153,000USD | 42,000USD | 137,000USD | 155,000USD |
| Net Income | -153,067,000USD | -5,178,000USD | 1,585,000USD | -7,448,000USD | -8,482,000USD | -12,257,000USD | -9,496,000USD | -8,660,000USD |
| Cost Of Revenue | — | 77,000USD | 3,206,000USD | 79,000USD | 100,000USD | — | — | — |
| Gross Profit | — | 5,686,000USD | 21,942,000USD | 2,069,999USD | 2,954,000USD | 421,000USD | 1,576,000USD | 3,336,000USD |
| Interest Income | — | 179,000USD | 158,000USD | 222,000USD | 198,000USD | 170,000USD | 290,000USD | 343,000USD |
| Interest Expense | — | 4,000USD | 51,000USD | 75,000USD | 45,000USD | 128,000USD | 153,000USD | 188,000USD |
| Income Before Tax | — | -5,178,000USD | 2,085,000USD | -7,448,000USD | -8,482,000USD | -12,257,000USD | -9,496,000USD | -8,660,000USD |
| Net Income From Continuing Ops | — | -5,178,000USD | 1,585,000USD | -7,448,000USD | -8,482,000USD | -12,257,000USD | -9,496,000USD | -8,660,000USD |
| Ebit | — | -5,174,000USD | 2,136,000USD | -7,373,000USD | -8,437,000USD | -12,129,000USD | -9,343,000USD | -8,472,000USD |
| Ebitda | — | -4,245,000USD | 3,342,000USD | -7,294,000USD | -7,641,000USD | -11,247,000USD | -9,245,000USD | -7,595,000USD |
| Depreciation And Amortization | — | 929,000USD | 1,206,000USD | 79,000USD | 796,000USD | 882,000USD | 98,000USD | 877,000USD |
| Reconciled Depreciation | — | 929,000USD | 1,206,000USD | 596,000USD | 796,000USD | 882,000USD | -238,000USD | 877,000USD |
| Income Tax Expense | — | — | 500,000USD | — | — | — | — | -8,660,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 27,466,000USD | 9,287,000USD | 5,490,000USD | 1,245,000USD | 14,941,370USD | 3,154,325USD | 3,458,000USD | 1,142,604USD |
| Cost Of Revenue | 3,480,000USD | 2,350,000USD | 38,097,000USD | 1,806,055USD | -1,777,985USD | 33,545,704USD | 27,487,485USD | 28,544,051USD |
| Gross Profit | 27,466,000USD | 9,287,000USD | -32,607,000USD | 1,245,000USD | 14,941,370USD | -30,391,379USD | 3,458,000USD | -27,401,447USD |
| Research Development | 37,743,000USD | 36,295,000USD | 40,802,000USD | 38,578,000USD | 41,346,765USD | 33,545,705USD | 27,487,000USD | 28,544,051USD |
| Selling General Administrative | 16,244,000USD | 14,585,000USD | 16,680,000USD | 16,169,000USD | 17,306,678USD | 14,651,205USD | 12,740,000USD | 11,295,211USD |
| Total Operating Expenses | 53,987,000USD | 50,787,000USD | 19,542,000USD | 54,470,000USD | 58,653,443USD | 14,651,206USD | 40,227,000USD | 39,839,262USD |
| Operating Income | -26,521,000USD | -41,500,000USD | -52,149,000USD | -53,225,000USD | -43,712,073USD | -45,042,585USD | -36,769,000USD | -38,696,658USD |
| Interest Income | 807,000USD | 1,622,000USD | 2,661,000USD | 928,242USD | 45,898USD | 463,914USD | 418,712USD | 376,008USD |
| Interest Expense | 357,000USD | 796,000USD | 1,245,000USD | 713,815USD | 1,732,087USD | 463,914USD | 5,648,592USD | 0USD |
| Net Interest Income | 450,000USD | 826,000USD | 1,416,000USD | 214,427USD | 45,898USD | 463,914USD | 418,712USD | 376,008USD |
| Income Before Tax | -26,102,000USD | -40,674,000USD | -50,733,000USD | -53,010,000USD | -43,666,175USD | -44,578,671USD | -36,286,000USD | -38,155,313USD |
| Income Tax Expense | 500,000USD | -40,674,000USD | 3,268,105USD | -214,427USD | 495,000USD | 206,250USD | 412,000USD | 825,000USD |
| Tax Provision | 500,000USD | 0USD | — | 0USD | 495,000USD | 206,250USD | 412,500USD | 825,000USD |
| Net Income | -26,602,000USD | -40,674,000USD | -50,733,000USD | -53,010,000USD | -44,161,175USD | -44,784,921USD | -36,698,000USD | -38,980,313USD |
| Net Income From Continuing Ops | -26,602,000USD | -40,674,000USD | -50,733,000USD | -53,010,382USD | -44,161,175USD | -44,784,921USD | -36,698,957USD | -38,980,313USD |
| Ebit | -25,745,000USD | -39,878,000USD | -49,488,000USD | -52,297,000USD | -43,712,073USD | -45,042,585USD | -36,769,000USD | -38,696,658USD |
| Ebitda | -22,265,000USD | -37,528,000USD | -46,052,000USD | -50,491,000USD | -45,490,058USD | -43,985,127USD | -31,603,408USD | -37,936,647USD |
| Depreciation And Amortization | 3,480,000USD | 2,350,000USD | 3,436,000USD | 1,806,000USD | -1,777,985USD | 1,057,458USD | 5,165,592USD | 760,011USD |
| Reconciled Depreciation | 3,480,000USD | 2,350,000USD | 3,436,000USD | 1,806,055USD | -1,777,985USD | 1,057,458USD | 5,165,592USD | 760,011USD |
| Total Other Income Expense Net | 419,000USD | 826,000USD | 1,416,000USD | 215,000USD | 45,898USD | 463,914USD | 483,000USD | 541,345USD |
| Unclassified Operating Expenses | — | — | -37,940,000USD | — | — | -33,545,704USD | — | — |
| Net Income Applicable To Common Shares | — | — | — | -53,010,382USD | -44,161,175USD | -44,784,921USD | -36,698,957USD | -38,980,313USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | 965,000USD | — |
| Non Operating Income Net Other | — | — | — | — | — | — | 64,078USD | 165,337USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 30,707,000USD | 30,877,000USD | 42,212,000USD | 31,644,000USD | 40,707,000USD | 22,254,000USD | 32,191,000USD | 44,810,000USD |
| Cash And Equivalents | 17,392,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 26,623,000USD | 26,392,000USD | 36,983,000USD | 25,819,000USD | 30,844,000USD | 15,931,000USD | 25,138,000USD | 37,256,000USD |
| Other Current Assets | 1,933,000USD | 4,662,000USD | 2,402,000USD | 4,861,000USD | 2,350,000USD | 2,795,000USD | 805,000USD | 1,684,000USD |
| Other Non Current Assets | 88,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 28,397,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 21,218,000USD | 7,391,000USD | 13,494,000USD | 15,524,000USD | 19,254,000USD | 15,498,000USD | 13,689,000USD | 16,790,000USD |
| Other Current Liabilities | 14,883,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 2,310,000USD | 21,608,000USD | 26,432,000USD | 13,246,000USD | 18,159,000USD | 6,580,000USD | 17,499,000USD | 25,366,000USD |
| Total Equity Including Noncontrolling Interest | 2,310,000USD | — | — | — | — | — | — | — |
| Net Receivables | 5,377,000USD | 5,351,000USD | 7,445,000USD | 2,286,000USD | 532,000USD | 0USD | 945,000USD | 3,152,000USD |
| Property Plant Equipment Net | 3,214,000USD | 3,606,000USD | 4,315,000USD | 4,909,000USD | 5,572,000USD | 4,112,000USD | 4,841,000USD | 4,604,000USD |
| Accounts Payable | 3,747,000USD | 3,327,000USD | 3,948,000USD | 2,348,000USD | 3,627,000USD | 3,784,000USD | 2,823,000USD | 6,474,000USD |
| Short Term Debt | 1,628,000USD | 1,562,000USD | 1,911,000USD | 3,489,000USD | 4,530,000USD | 6,949,000USD | 7,873,000USD | 6,858,000USD |
| Common Stock | 5,000USD | 3,000USD | 97,000USD | 78,000USD | 76,000USD | 62,000USD | 62,000USD | 60,000USD |
| Retained Earnings | -526,711,000USD | -373,644,000USD | -368,466,000USD | -370,051,000USD | -362,603,000USD | -354,121,000USD | -341,864,000USD | -332,368,000USD |
| Total Liab | — | 9,269,000USD | 15,780,000USD | 18,398,000USD | 22,548,000USD | 15,674,000USD | 14,692,000USD | 19,444,000USD |
| Other Current Liab | — | 2,502,000USD | 7,635,000USD | 1,871,000USD | 11,097,000USD | 4,765,000USD | 2,993,000USD | 3,199,000USD |
| Capital Stock | — | 3,000USD | 97,000USD | 78,000USD | 76,000USD | 62,000USD | 62,000USD | 60,000USD |
| Cash | — | 16,379,000USD | 27,136,000USD | 11,701,000USD | 27,492,000USD | 13,136,000USD | 22,459,000USD | 32,420,000USD |
| Cash And Short Term Investments | — | 16,379,000USD | 27,136,000USD | 18,672,000USD | 27,962,000USD | 13,136,000USD | 23,388,000USD | 32,420,000USD |
| Net Debt | — | -12,939,000USD | -22,939,000USD | -5,528,000USD | -19,858,000USD | -6,011,000USD | -13,583,001USD | -22,908,000USD |
| Short Long Term Debt Total | — | 3,440,000USD | 4,197,000USD | 6,173,000USD | 7,634,000USD | 7,125,000USD | 8,875,999USD | 9,512,000USD |
| Property Plant Equipment Gross | — | 7,343,000USD | 7,978,000USD | 8,506,000USD | 9,446,000USD | 7,889,000USD | 8,521,000USD | 8,504,000USD |
| Common Stock Shares Outstanding | — | 4,807,494shares | 3,683,765shares | 3,362,312shares | 3,181,980shares | 2,475,157shares | 2,474,611shares | 1,707,657shares |
| Non Current Assets Total | — | 4,485,000USD | 5,229,000USD | 5,824,999USD | 9,863,000USD | 6,323,000USD | 7,053,000USD | 7,554,000USD |
| Non Current Liabilities Total | — | 1,878,000USD | 2,286,000USD | 2,874,000USD | 3,294,000USD | 176,000USD | 1,003,000USD | 2,654,000USD |
| Non Currrent Assets Other | — | 879,000USD | 5,075,000USD | 762,999USD | 4,291,000USD | 2,058,000USD | 2,212,000USD | 2,950,000USD |
| Net Working Capital | — | 19,001,000USD | 23,489,000USD | 10,295,000USD | 11,590,000USD | 433,000USD | 11,449,000USD | 20,466,000USD |
| Unclassified Non Current Liabilities | — | 1,878,000USD | 2,286,000USD | 2,874,000USD | 3,294,000USD | — | 1,003,000USD | 1,326,000USD |
| Unclassified Equity | — | 395,246,000USD | 394,704,000USD | 383,140,000USD | 380,610,000USD | 360,577,000USD | 359,239,000USD | 357,614,000USD |
| Other Assets | — | — | 15,076,000USD | — | — | — | — | — |
| Unclassified Non Current Assets | — | — | -19,237,000USD | — | — | — | — | — |
| Current Deferred Revenue | — | — | — | 7,816,000USD | — | — | 85,000USD | 259,000USD |
| Short Long Term Debt | — | — | — | 1,458,000USD | 2,416,000USD | 3,374,000USD | 4,333,000USD | 3,963,000USD |
| Short Term Investments | — | — | — | 6,971,000USD | 470,000USD | — | 929,000USD | — |
| Accumulated Other Comprehensive Income | — | — | — | 1,000USD | 0USD | — | — | — |
| Unclassified Current Liabilities | — | — | — | -1,458,000USD | -2,416,000USD | -3,374,000USD | -4,418,000USD | -3,963,000USD |
| Long Term Debt | — | — | — | — | — | — | — | 1,328,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 42,212,000USD | 32,191,000USD | 61,530,000USD | 91,283,000USD | 83,400,935USD | 99,533,800USD | 71,605,009USD | 45,363,100USD |
| Other Current Assets | 2,402,000USD | 805,000USD | 1,242,000USD | 841,000USD | 954,792USD | 1,241,239USD | 860,107USD | 1,397,356USD |
| Total Liab | 15,780,000USD | 14,692,000USD | 24,445,000USD | 25,601,000USD | 17,908,863USD | 20,622,328USD | 17,021,113USD | 11,391,631USD |
| Total Stockholder Equity | 26,432,000USD | 17,499,000USD | 37,085,000USD | 65,682,000USD | 65,492,072USD | 78,911,472USD | 54,583,896USD | 33,971,469USD |
| Other Current Liab | 7,635,000USD | 2,993,000USD | 4,137,000USD | 3,554,000USD | 2,651,810USD | 2,787,211USD | 6,324,795USD | 2,169,527USD |
| Common Stock | 97,000USD | 62,000USD | 47,000USD | 43,000USD | 32,202USD | 30,351USD | 26,562USD | 20,697USD |
| Capital Stock | 97,000USD | 62,000USD | 47,000USD | 43,042USD | 32,202USD | 30,351USD | 26,562USD | 20,697USD |
| Retained Earnings | -368,466,000USD | -341,864,000USD | -301,190,000USD | -250,457,000USD | -197,446,214USD | -153,285,039USD | -108,500,118USD | -71,801,161USD |
| Cash | 27,136,000USD | 22,459,000USD | 48,514,000USD | 51,614,000USD | 64,370,800USD | 74,866,133USD | 44,290,030USD | 20,800,284USD |
| Cash And Short Term Investments | 27,136,000USD | 23,388,000USD | 48,514,000USD | 76,289,000USD | 64,370,800USD | 84,868,683USD | 59,409,955USD | 39,212,784USD |
| Total Current Assets | 36,983,000USD | 25,138,000USD | 51,454,000USD | 77,187,000USD | 68,468,119USD | 87,527,404USD | 61,024,960USD | 40,610,140USD |
| Total Current Liabilities | 13,494,000USD | 13,689,000USD | 17,081,000USD | 11,548,000USD | 12,787,684USD | 16,315,966USD | 11,655,248USD | 6,216,879USD |
| Net Debt | -22,939,000USD | -13,583,001USD | -33,819,000USD | -32,298,000USD | -52,349,793USD | -67,719,919USD | -38,494,272USD | -20,800,284USD |
| Short Term Debt | 1,911,000USD | 7,873,000USD | 7,331,000USD | 5,263,000USD | 6,899,828USD | 4,777,427USD | 4,447,787USD | — |
| Short Long Term Debt Total | 4,197,000USD | 8,875,999USD | 14,695,000USD | 19,316,000USD | 12,021,007USD | 7,146,214USD | 5,795,758USD | — |
| Net Receivables | 7,445,000USD | 945,000USD | 1,698,000USD | 57,000USD | 3,142,527USD | 1,417,482USD | 754,898USD | — |
| Accounts Payable | 3,948,000USD | 2,823,000USD | 3,501,000USD | 2,731,000USD | 2,590,701USD | 2,070,303USD | 882,666USD | 2,035,354USD |
| Property Plant Equipment Net | 4,315,000USD | 4,841,000USD | 7,118,000USD | 10,702,000USD | 11,921,825USD | 8,882,253USD | 7,183,948USD | 2,781,459USD |
| Property Plant Equipment Gross | 7,978,000USD | 8,521,000USD | 10,734,000USD | 14,943,430USD | 15,365,698USD | 8,882,253USD | 7,183,948USD | 2,781,459USD |
| Common Stock Shares Outstanding | 3,157,726shares | 1,877,612shares | 1,525,160shares | 1,188,304shares | 1,042,847shares | 956,287shares | 734,726shares | 671,135shares |
| Non Current Assets Total | 5,229,000USD | 7,053,000USD | 10,076,000USD | 14,096,000USD | 14,932,816USD | 12,006,396USD | 10,580,049USD | 4,752,960USD |
| Non Current Liabilities Total | 2,286,000USD | 1,003,000USD | 7,364,000USD | 14,053,000USD | 5,121,179USD | 4,306,362USD | 5,365,865USD | 5,174,752USD |
| Non Currrent Assets Other | 760,000USD | 2,212,000USD | 2,807,000USD | 3,394,000USD | 2,860,991USD | 3,124,143USD | 3,384,434USD | 1,821,501USD |
| Net Working Capital | 23,489,000USD | 11,449,000USD | 34,373,000USD | 65,638,939USD | 55,680,435USD | 71,211,438USD | 49,369,712USD | 34,393,261USD |
| Unclassified Non Current Liabilities | 2,286,000USD | 1,003,000USD | 3,162,000USD | — | — | -2,197,867USD | -4,017,894USD | -5,558,752USD |
| Unclassified Equity | 394,704,000USD | 359,239,000USD | 338,181,000USD | 316,148,958USD | 262,873,882USD | 232,128,678USD | 163,041,211USD | 105,742,194USD |
| Current Deferred Revenue | — | 85,000USD | 2,112,000USD | — | 645,345USD | 6,681,025USD | 4,097,443USD | 2,011,998USD |
| Short Long Term Debt | — | 4,333,000USD | 3,963,000USD | 1,963,028USD | — | — | — | — |
| Short Term Investments | — | 929,000USD | 0USD | 24,675,000USD | 0USD | 10,002,550USD | 15,119,925USD | 18,412,500USD |
| Unclassified Current Liabilities | — | -4,418,000USD | -3,963,000USD | -1,963,028USD | — | — | -4,097,443USD | — |
| Long Term Debt | — | — | 4,202,000USD | 8,034,729USD | — | — | — | — |
| Inventory | — | — | 1USD | 1USD | 1USD | — | 15,119,995USD | — |
| Other Assets | — | — | — | 3,394,045USD | 3,010,991USD | 3,124,143USD | 3,384,434USD | 1,971,501USD |
| Accumulated Other Comprehensive Income | — | — | — | -96,000USD | 0USD | 7,131USD | -10,321USD | -10,958USD |
| Non Current Liabilities Other | — | — | — | 6,017,613USD | 5,121,179USD | 4,306,362USD | 5,365,865USD | 5,174,752USD |
| Net Tangible Assets | — | — | — | 65,682,575USD | 65,492,072USD | 78,911,472USD | 54,572,229USD | 33,971,469USD |
| Unclassified Non Current Assets | — | — | — | -3,394,045USD | -2,860,991USD | -3,124,143USD | -3,384,434USD | -1,821,501USD |
| Deferred Long Term Liab | — | — | — | — | — | 260,292USD | — | 384,000USD |
| Other Liab | — | — | — | — | — | 1,937,575USD | 4,017,894USD | 5,174,752USD |
| Intangible Assets | — | — | — | — | — | — | 11,667USD | — |
| Unclassified Current Assets | — | — | — | — | — | — | -15,119,995USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 602,000USD |
| Stock Based Compensation | 23,886,000USD |
| Change To Account Receivables | 169,000USD |
| Change To Liabilities | 15,523,000USD |
| Change In Working Capital | -1,145,000USD |
| Operating Cash Flow | -39,946,000USD |
| Capital Expenditures | -121,000USD |
| Investing Cash Flow | -121,000USD |
| Financing Cash Flow | 30,323,000USD |
| Change In Cash | -9,744,000USD |
| End Cash Flow | 17,546,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -5,178,000USD | 1,585,000USD | -7,448,000USD | -8,482,000USD | -12,257,000USD | -9,496,000USD | -8,660,000USD | -10,171,000USD |
| Depreciation | 566,000USD | 1,459,000USD | 79,000USD | 796,000USD | 882,000USD | -238,000USD | 877,000USD | 862,000USD |
| Stock Based Compensation | 48,000USD | 610,000USD | 1,533,000USD | 1,263,000USD | 1,338,000USD | 1,562,000USD | 1,583,000USD | 1,755,000USD |
| Other Non Cash Items | 353,000USD | -262,000USD | 1,962,000USD | 42,000USD | 41,000USD | 45,000USD | -55,000USD | 42,000USD |
| Change To Account Receivables | 195,000USD | -5,159,000USD | 145,000USD | -2,431,000USD | 945,000USD | 2,207,000USD | -1,305,000USD | -447,000USD |
| Change In Working Capital | -6,731,000USD | -4,468,000USD | -3,617,000USD | 2,966,000USD | 1,824,000USD | -901,000USD | -1,272,000USD | -2,478,000USD |
| Total Cash From Operating Activities | -10,942,000USD | -1,076,000USD | -9,024,000USD | -3,415,000USD | -8,172,000USD | -9,028,000USD | -7,527,000USD | -9,990,000USD |
| Capital Expenditures | -121,000USD | 0USD | 0USD | -27,000USD | -150,000USD | -2,000USD | -1,000USD | -10,000USD |
| Free Cash Flow | -11,063,000USD | -1,076,000USD | -9,024,000USD | -3,442,000USD | -8,322,000USD | -9,030,000USD | -7,526,000USD | -10,000,000USD |
| Total Cashflows From Investing Activities | -121,000USD | 7,020,000USD | -6,768,000USD | -27,000USD | -150,000USD | -1,000USD | 98,000USD | -10,000USD |
| Net Borrowings | 0USD | -1,500,000USD | -1,000,000USD | -1,000,000USD | -1,000,000USD | -999,000USD | -1,000,000USD | — |
| Total Cash From Financing Activities | 306,000USD | 9,492,000USD | 1,000USD | 17,798,000USD | -1,000,000USD | -932,000USD | 9,821,000USD | -1,000,000USD |
| Issuance Of Capital Stock | 306,000USD | 10,992,000USD | 1,001,000USD | 18,798,000USD | 0USD | 49,000USD | 10,821,000USD | 0USD |
| Change In Cash | -10,757,000USD | 15,436,000USD | -15,791,000USD | 14,356,000USD | -9,322,000USD | -9,961,000USD | 2,392,000USD | -11,000,000USD |
| Begin Period Cash Flow | 27,290,000USD | 11,854,000USD | 27,492,000USD | 13,289,000USD | 22,611,000USD | 32,572,000USD | 30,180,000USD | 41,180,000USD |
| End Period Cash Flow | 16,533,000USD | 27,290,000USD | 11,701,000USD | 27,645,000USD | 13,289,000USD | 22,611,000USD | 32,572,000USD | 30,180,000USD |
| Other Cashflows From Financing Activities | 306,000USD | 9,492,000USD | 1,000USD | 17,798,000USD | -1,000,000USD | 18,000USD | 98,000USD | -10,000USD |
| Investments | — | 7,000,000USD | -6,768,000USD | -27,000USD | -150,000USD | -1,000USD | 98,000USD | -10,000USD |
| Other Cashflows From Investing Activities | — | 30,000USD | 9,702,000USD | — | — | 1,000USD | 97,000USD | — |
| Unclassified Financing Cash Flow | — | -9,492,000USD | — | -17,798,000USD | — | — | — | — |
| Unclassified Operating Cash Flow | — | — | -1,533,000USD | — | — | — | — | — |
| Unclassified Investing Cash Flow | — | — | -9,702,000USD | — | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -26,602,000USD | -40,674,000USD | -50,733,000USD | -53,010,000USD | -44,161,175USD | -44,784,921USD | -36,698,957USD | -38,980,313USD |
| Depreciation | 958,000USD | 2,350,000USD | 3,436,000USD | 1,806,000USD | -1,777,985USD | -3,145,022USD | 5,165,592USD | 760,011USD |
| Stock Based Compensation | 4,744,000USD | 6,846,000USD | 8,180,000USD | 9,496,000USD | 11,515,584USD | 10,480,782USD | 6,520,982USD | 7,173,713USD |
| Other Non Cash Items | 2,508,000USD | 74,000USD | 90,000USD | -454,000USD | -26,131USD | -479,538USD | -4,277,544USD | 345,101USD |
| Change To Account Receivables | -6,500,000USD | 753,000USD | -1,641,000USD | 3,085,000USD | -1,725,045USD | -662,584USD | -754,898USD | -754,898USD |
| Change In Working Capital | -3,295,000USD | -4,925,000USD | -934,000USD | 356,000USD | -4,387,459USD | 5,434,665USD | -1,488,793USD | 4,210,661USD |
| Total Cash From Operating Activities | -21,687,000USD | -36,329,000USD | -39,961,000USD | -41,806,000USD | -38,837,166USD | -32,494,034USD | -30,796,910USD | -26,410,968USD |
| Capital Expenditures | -177,000USD | -66,000USD | 0USD | -171,000USD | -913,039USD | -595,259USD | -46,353USD | -1,854,246USD |
| Free Cash Flow | -21,864,000USD | -36,395,000USD | -39,961,000USD | -41,977,000USD | -39,750,205USD | -33,089,293USD | -30,843,263USD | -28,265,214USD |
| Investments | 212,000USD | 32,000USD | 25,002,000USD | -29,445,336USD | 10,000,000USD | -9,948,867USD | -15,134,324USD | -39,500,000USD |
| Total Cashflows From Investing Activities | 75,000USD | 32,000USD | 25,002,000USD | -24,610,000USD | 9,108,511USD | 4,455,874USD | 3,446,823USD | -20,354,246USD |
| Net Borrowings | -4,500,000USD | -3,999,000USD | -2,000,000USD | 14,558,250USD | 10,000,000USD | 10,000,000USD | 10,000,000USD | — |
| Total Cash From Financing Activities | 26,291,000USD | 10,243,000USD | 11,860,000USD | 53,659,000USD | 19,233,322USD | 58,614,263USD | 50,789,765USD | 4,181,849USD |
| Issuance Of Capital Stock | 30,791,000USD | 14,224,000USD | 13,387,000USD | 39,300,756USD | 17,384,668USD | 56,682,236USD | 48,998,907USD | 4,169,349USD |
| Change In Cash | 4,679,000USD | -26,054,000USD | -3,099,000USD | -12,757,000USD | -10,495,333USD | 30,576,103USD | 23,439,678USD | -42,583,365USD |
| Begin Period Cash Flow | 22,611,000USD | 48,665,000USD | 51,764,000USD | 64,521,000USD | 75,016,133USD | 44,440,030USD | 21,000,352USD | 63,583,717USD |
| End Period Cash Flow | 27,290,000USD | 22,611,000USD | 48,665,000USD | 51,764,000USD | 64,520,800USD | 75,016,133USD | 44,440,030USD | 21,000,352USD |
| Other Cashflows From Investing Activities | 212,000USD | 98,000USD | 2,000USD | 6,000USD | 21,550USD | -83,694USD | 3,493,176USD | -18,500,000USD |
| Other Cashflows From Financing Activities | 26,291,000USD | 18,000USD | 473,000USD | 4,359,000USD | 1,848,654USD | 1,932,027USD | 1,790,858USD | 12,500USD |
| Unclassified Financing Cash Flow | -26,291,000USD | — | — | 35,141,623USD | 8,134,796USD | 46,953,287USD | 39,089,934USD | — |
| Change To Liabilities | — | — | — | -987,470USD | 2,353,150USD | 1,301,124USD | -713,398USD | 1,013,122USD |
| Dividends Paid | — | — | — | -199,873USD | — | — | — | — |
| Sale Purchase Of Stock | — | — | — | -200,000USD | -750,128USD | -271,051USD | -91,027USD | 4,181,849USD |
| Cash And Cash Equivalents Changes | — | — | — | -12,756,698USD | -10,495,333USD | 30,576,103USD | 23,439,678USD | -42,583,365USD |
| Unclassified Investing Cash Flow | — | — | — | 5,000,336USD | — | 15,083,694USD | 15,134,324USD | 39,500,000USD |
| Change To Inventory | — | — | — | — | 4,790,443USD | 4,852,721USD | -509,795USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.